Back

Prevalence of cardiovascular comorbidities among hospitalized patients with hypertrophic cardiomyopathy and factors associated with a higher case-fatality rate

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Novel insights into Brugada syndrome and hypertrophic cardiomyopathy Hypertrophic Cardiomyopathy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Saeed Shoar

University of Maryland Capital Region Medical Center, Largo (United States of America)

7 More presentations in this session

Presentation thumbnail
Relationship between epicardial adipose tissue and ventricular fibrillation in Brugada syndrome by cardiac computed tomography analysis
Mr K. Yonezu (Yufu City, JP)
Abstract Slides Video
Presentation thumbnail
Prognostic parameters predict cardiac events in Brugada syndrome: a meta-analysis
Mr P. Pajareya (Bangkok, TH)
Abstract Slides Video
Presentation thumbnail
Refining risk stratification in hypertrophic cardiomyopathy: the role of late gadolinium enhancement and syncope in predicting adverse outcomes
Doctor C. Mann (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
Novel electric predictors of lethal arrhythmic event in patients with hypertrophic cardiomyopathy
Professor J. Choi (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Nationwide trends in utilization and safety of ventricular arrythmia ablation in patients with hypertrophic cardiomyopathy
Doctor G. Rozen (Boston, US)
Abstract Slides Video

Access the full session

Session thumbnail
Novel insights into Brugada syndrome and hypertrophic cardiomyopathy

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Comparisons in cardiovascular outcomes and mortality in patients diagnosed with hypertrophic cardiomyopathy
thumbnail
Congress Presentation
The influence of genotype on the phenotype and prognosis of patients with hypertrophic cardiomyopathy
thumbnail
Congress Presentation
Clinical burden of obstructive and non-obstructive hypertrophic cardiomyopathy: insights from a nationwide study in France

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources